title: One good DNA-damage deserves another: Oxaliplatin in MSI-high colon cancer.
authors: Yale Cancer Center and School of Medicine, New Haven CT Mayo Clinic, Rochester MN howard.hochster@yale.edu.
authors: Howard S
authors: HS
authors: Hochster
authors: Yale Cancer Center and School of Medicine, New Haven CT Mayo Clinic, Rochester MN.
authors: Daniel J
authors: DJ
authors: Sargent
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D015179:Colorectal Neoplasms; D005260:Female; D006801:Humans; D008297:Male; D053842:Microsatellite Instability; D009386:Neoplastic Syndromes, Hereditary; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011743:Pyrimidines